Open Access
REVIEW
Ibrahim M. Ibrahim1, Shadab Md2,*
1 Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
2 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
* Corresponding Author: Shadab Md. Email:
(This article belongs to the Special Issue: Bioactive Natural Components as Regulators of Cellular Pathways and Disease Progression)
BIOCELL https://doi.org/10.32604/biocell.2026.077548
Received 11 December 2025; Accepted 25 February 2026; Published online 12 March 2026
View
Download
Like
Glucocorticoid reduces the efficacy of afatinib on the head and neck squamous cell carcinoma
DONGYANG WANG, YI CHEN, JING HUANG,...PSTCNN: Explainable COVID-19 diagnosis using PSO-guided self-tuning CNN
WEI WANG, YANRONG PEI, SHUI-HUA...The progress of combination therapy with immune checkpoint inhibitors in breast cancer
KAIMIN FAN, JUNWEI WENG